MEP23508A - Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems - Google Patents
Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systemsInfo
- Publication number
- MEP23508A MEP23508A MEP-235/08A MEP23508A MEP23508A ME P23508 A MEP23508 A ME P23508A ME P23508 A MEP23508 A ME P23508A ME P23508 A MEP23508 A ME P23508A
- Authority
- ME
- Montenegro
- Prior art keywords
- drug
- delivery
- comtrolling
- compositions
- methods
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013271 transdermal drug delivery Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51530603P | 2003-10-28 | 2003-10-28 | |
YUP-2006/0332A RS20060332A (en) | 2003-10-28 | 2004-10-28 | Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems |
PCT/US2004/035556 WO2005042055A2 (fr) | 2003-10-28 | 2004-10-28 | Compositions et procedes de controle de perte et d'administration de medicaments dans des systemes d'administration de medicaments par voie transdermique |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP23508A true MEP23508A (en) | 2010-06-10 |
Family
ID=34549389
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-235A ME00114B (me) | 2003-10-28 | 2004-10-28 | Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka |
MEP-235/08A MEP23508A (en) | 2003-10-28 | 2004-10-28 | Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-235A ME00114B (me) | 2003-10-28 | 2004-10-28 | Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka |
Country Status (19)
Country | Link |
---|---|
US (3) | US8703175B2 (fr) |
EP (1) | EP1682061B1 (fr) |
JP (2) | JP2007509951A (fr) |
KR (1) | KR20060114338A (fr) |
CN (1) | CN100457064C (fr) |
AU (1) | AU2004285505B2 (fr) |
BR (1) | BRPI0416063A (fr) |
CA (1) | CA2542778C (fr) |
ES (1) | ES2626784T3 (fr) |
GE (1) | GEP20084561B (fr) |
IL (1) | IL174894A0 (fr) |
ME (2) | ME00114B (fr) |
NO (1) | NO20062434L (fr) |
NZ (1) | NZ546992A (fr) |
RS (1) | RS20060332A (fr) |
RU (1) | RU2356580C2 (fr) |
UA (1) | UA84303C2 (fr) |
WO (1) | WO2005042055A2 (fr) |
ZA (1) | ZA200603300B (fr) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1061900E (pt) * | 1999-01-14 | 2005-04-29 | Noven Pharma | Composicoes e metodos para libertacao de uma droga |
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
EP1682102A2 (fr) * | 2003-09-10 | 2006-07-26 | Noven Pharmaceuticals, Inc. | Dispositif multicouche d'administration transdermique de medicaments |
JP2007511605A (ja) * | 2003-11-18 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | オランザピン含有経皮薬物送達組成物 |
AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US8343538B2 (en) * | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
WO2006041911A2 (fr) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Dispositif d'administration transdermique de medicaments contenant des polymeres acryliques |
KR100764679B1 (ko) * | 2005-07-22 | 2007-10-09 | 익수제약 주식회사 | 파록세틴을 함유하는 경피투여용 패취제 |
CA2629046C (fr) * | 2005-12-13 | 2014-04-08 | Biodelivery Sciences International, Inc. | Dispositif resistant aux abus pour l'administration transmucosale de medicaments |
DE102006026060B4 (de) * | 2006-01-12 | 2013-01-31 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme |
JP5336351B2 (ja) * | 2006-03-24 | 2013-11-06 | オクシリウム インターナショナル ホールディングス,インコーポレイティド | ホットメルト押出しラミネートの調製方法 |
CN101484142B (zh) | 2006-03-24 | 2013-06-05 | 奥克思利尤姆国际控股公司 | 包含对碱性不稳定的药物的稳定组合物 |
WO2007112287A2 (fr) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Compositions transdermiques extrudées à chaud contenant de la testostérone |
WO2008011194A2 (fr) | 2006-07-21 | 2008-01-24 | Biodelivery Sciences International, Inc. | Dispositifs d'administration transmuqueuse avec absorption accrue |
US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
CA2670749A1 (fr) * | 2006-12-05 | 2008-06-12 | Landec Corporation | Administration de medicaments |
US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
AU2008275101B2 (en) | 2007-07-10 | 2014-08-21 | Agile Therapeutics, Inc. | Dermal delivery device with in situ seal |
WO2009026135A2 (fr) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Système d'administration transdermique commandée de bisoprolol |
WO2009026133A2 (fr) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Système d'administration transdermique de bisoprolol |
US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
US8231906B2 (en) * | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
CA2733265A1 (fr) * | 2008-09-30 | 2010-04-08 | Teikoku Pharma Usa, Inc. | Compositions de donepezil a administration transdermique etendue et leurs procedes d'utilisation |
MX2011003510A (es) | 2008-10-02 | 2011-06-17 | Mylan Inc | Metodo para fabricar un laminado adhesivo de multiples capas. |
WO2010121033A2 (fr) * | 2009-04-17 | 2010-10-21 | 3M Innovative Properties Company | Construction adhésive en gel de silicone |
KR101670379B1 (ko) * | 2009-07-31 | 2016-10-28 | (주)씨엘팜 | 니코틴 경피 전달 패취 |
EP2729148A4 (fr) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson |
SG11201401446RA (en) | 2011-08-18 | 2014-09-26 | Biodelivery Sciences Int Inc | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
FR2987561B1 (fr) * | 2012-03-02 | 2014-04-11 | Pf Medicament | Dispositif transdermique comprenant des micro-particules poreuses |
CA2891467A1 (fr) * | 2012-10-15 | 2014-04-24 | Noven Pharmaceuticals, Inc. | Compositions et procedes pour l'administration transdermique de methylphenidate |
TWI632923B (zh) | 2012-10-25 | 2018-08-21 | 諾芬藥品公司 | 用於經皮傳遞安非他命(amphetamine)之組合物及方法 |
CN103845220B (zh) * | 2012-12-04 | 2017-09-01 | 日绊株式会社 | 贴附剂 |
WO2014106014A1 (fr) | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc | Systèmes d'administration de médicament transdermique pour lévonorgestrel et éthinyl estradiol |
MX2015008284A (es) * | 2012-12-28 | 2015-12-03 | Noven Pharma | Composiciones y metodos para suministro transdermico de agentes no esteroidales anti-inflamatorios. |
CA2896055C (fr) * | 2012-12-28 | 2021-02-16 | Noven Pharmaceuticals, Inc. | Compositions et procedes pour l'administration transdermique d'amphetamine et de clonidine |
WO2014106016A1 (fr) | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc | Compositions multipolymères pour l'administration transdermique de médicaments |
US11337936B2 (en) | 2013-03-14 | 2022-05-24 | Noven Pharmaceuticals, Inc. | Amphetamine transdermal compositions with acrylic block copolymer |
US20140276483A1 (en) * | 2013-03-14 | 2014-09-18 | Noven Pharmaceuticals, Inc. | Transdermal methylphenidate compositions with acrylic block copolymers |
AR095259A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
AR095260A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones de anfetaminas transdérmicas estables y métodos de fabricación |
CN103432104B (zh) * | 2013-08-09 | 2015-10-28 | 大连理工大学 | 一种含有普拉克索的透皮贴剂 |
EP3054935B1 (fr) | 2013-10-07 | 2020-12-09 | Teikoku Pharma USA, Inc. | Méthodes et compositions permettant de traiter le trouble d'hyperactivité avec déficit de l'attention, l'anxiété et l'insomnie à l'aide de compositions transdermiques de dexmédétomidine |
CN105764496B (zh) * | 2013-10-07 | 2020-09-25 | 帝国制药美国公司 | 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物 |
US20160374956A1 (en) * | 2013-12-12 | 2016-12-29 | Hisamitsu Pharmaceutical Co., Inc. | Multilayer type patch |
AU2014370133A1 (en) * | 2013-12-23 | 2016-08-04 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine |
JP6689254B2 (ja) * | 2014-07-31 | 2020-04-28 | ノーヴェン ファーマシューティカルズ インコーポレイテッド | 経皮薬物送達組成物のためのシリコーン含有アクリルポリマー |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
WO2016123418A1 (fr) | 2015-01-29 | 2016-08-04 | Dow Corning Corporation | Compositions d'acrylate de silicone et procédés pour les préparer |
AU2016215180B2 (en) | 2015-02-06 | 2020-01-02 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
US10406116B2 (en) | 2015-02-06 | 2019-09-10 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
KR101897174B1 (ko) | 2016-08-17 | 2018-09-12 | (주)오스힐 | 연부조직질환 치료용 경피약물전달 촉진장치 |
EP3522843B1 (fr) * | 2016-10-07 | 2022-09-21 | Transwell Biotech Co., Ltd. | Système d'administration transdermique de pramipexole et ses utilisations |
RU2762896C2 (ru) | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
RU2764443C2 (ru) | 2016-12-20 | 2022-01-17 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен |
CA3048897A1 (fr) * | 2016-12-29 | 2018-07-05 | Pure Ratios Holdings, Inc. | Systeme d'administration transdermique modulaire et procedes de fabrication et d'utilisation associes |
US11285306B2 (en) | 2017-01-06 | 2022-03-29 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
WO2019002204A1 (fr) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Système thérapeutique transdermique contenant de l'asénapine et un polymère hybride acrylique de type silicone |
EP3801732A4 (fr) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Procédés et systèmes d'administration de médicament |
CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
WO2020092990A1 (fr) * | 2018-11-02 | 2020-05-07 | Eastern Virginia Medical School | Compositions pharmaceutiques et procédés de fabrication d'une formulation de timbre pour administration transdermique |
EP4003256A4 (fr) * | 2019-07-30 | 2023-05-24 | Kai P. Leung | Composite stratifié pour le traitement et la prévention de cicatrices |
US11559501B2 (en) | 2021-01-07 | 2023-01-24 | Noven Pharmaceuticals, Inc. | Transdermal amphetamine compositions with low levels of carbamate |
AR124578A1 (es) | 2021-01-07 | 2023-04-12 | Noven Pharma | Compuestos de carbamato de anfetamina y métodos relacionados |
WO2023240478A1 (fr) * | 2022-06-15 | 2023-12-21 | Dow Silicones Corporation | Composition de revêtement pelable et son utilisation |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843368B2 (ja) | 1980-10-30 | 1983-09-27 | 日東電工株式会社 | 消炎鎮痛貼付剤 |
GB2105990B (en) | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
US4559222A (en) | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4584355A (en) | 1984-10-29 | 1986-04-22 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I |
US4585836A (en) | 1984-10-29 | 1986-04-29 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II |
US4655767A (en) | 1984-10-29 | 1987-04-07 | Dow Corning Corporation | Transdermal drug delivery devices with amine-resistant silicone adhesives |
US4591622A (en) | 1984-10-29 | 1986-05-27 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product thereof |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US4911707A (en) | 1987-02-13 | 1990-03-27 | Ciba-Geigy Corporation | Monolithic user-activated transdermal therapeutic system |
US4746515A (en) | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US4983395A (en) | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4915950A (en) | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US4994278A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4994267A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3905050A1 (de) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii) |
US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
US5271940A (en) | 1989-09-14 | 1993-12-21 | Cygnus Therapeutic Systems | Transdermal delivery device having delayed onset |
JPH06505712A (ja) * | 1990-11-28 | 1994-06-30 | サノ・コーポレーシヨン | タバコ中毒の処理方法および装置 |
US5633009A (en) | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
CA2075517C (fr) * | 1992-04-01 | 1997-03-11 | John Wick | Piece transdermique incorporant une pellicule de polymeres incorporee a l'aide d'un agent actif |
JP2960832B2 (ja) | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | エストラジオールの投与システム |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
US5462746A (en) * | 1992-11-02 | 1995-10-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
JP2569396B2 (ja) * | 1992-12-04 | 1997-01-08 | 株式会社太平洋 | 経皮投与型薬物用貼付剤 |
HU223045B1 (hu) | 1993-04-20 | 2004-03-01 | Hexal Ag. | Ösztrogén vagy progesztagén hormont tartalmazó tapasz |
US5762952A (en) | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
US5567488A (en) | 1993-09-16 | 1996-10-22 | The Dow Chemical Company | Multilayer barrier film for transdermal drug delivery system and ostomy applications |
DE4332094C2 (de) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung |
US5723145A (en) * | 1993-09-30 | 1998-03-03 | Takiron Co., Ltd. | Transdermal absorption preparation |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
US5474787A (en) | 1994-10-21 | 1995-12-12 | The Wm. Wrigley Jr. Company | Chewing gum containing a lecithin/glycerol triacetate blend |
FR2728463A1 (fr) * | 1994-12-21 | 1996-06-28 | Lhd Lab Hygiene Dietetique | Systeme transdermique d'administration simultanee de plusieurs principes actifs |
CA2223588C (fr) | 1995-06-07 | 2004-01-06 | Noven Pharmaceuticals, Inc. | Compositions transdermiques contenant des medicaments de faible poids moleculaire liquides a temperature ambiante |
US5906830A (en) | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
US5902603A (en) | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
FR2749586B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments |
JP2001511159A (ja) * | 1997-02-07 | 2001-08-07 | シナプス・ファーマシューティカルズ・インターナショナル・インコーポレイテッド | オキシムを含むシナプス機能障害の処置用医薬組成物 |
DE19738855C2 (de) | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
ES2252865T3 (es) | 1997-09-26 | 2006-05-16 | Noven Pharmaceuticals, Inc. | Composiciones bioadhesivas y metodos para la administracion topica de agentes activos. |
US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
EP1449527A3 (fr) | 1998-12-07 | 2004-09-08 | Elan Pharma International Limited | Patch transdermique pour administrer un principe actif volatile |
EP1137406B2 (fr) | 1998-12-07 | 2008-01-23 | J. Dev Limited | Timbre transdermique pour administrer des medicaments liquides volatiles |
US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
KR20010036685A (ko) | 1999-10-11 | 2001-05-07 | 김윤 | 펜타닐을 함유하는 매트릭스형 경피투여제 |
DE19950066A1 (de) | 1999-10-16 | 2001-04-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut |
DK1242012T3 (da) * | 1999-11-24 | 2010-04-26 | Agile Therapeutics Inc | Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde |
DE60119140T2 (de) | 2000-09-24 | 2007-02-08 | 3M Innovative Properties Co., St. Paul | Trocknungsverfahren zur selektiven entfernung flüchtiger bestandteile aus nassen beschichtungen |
CA2427388C (fr) * | 2000-11-01 | 2011-12-20 | Sention, Inc. | Compositions pharmaceutiques et leurs utilisations pour ameliorer les troubles de la memoire et de l'apprentissage |
US6448303B1 (en) | 2000-12-29 | 2002-09-10 | National Starch And Chemical Investment Holding Corporation | Hot melt adhesives for dermal application |
JP4323138B2 (ja) | 2002-06-05 | 2009-09-02 | 日東電工株式会社 | 経皮吸収型製剤およびその製造方法 |
EP1682102A2 (fr) | 2003-09-10 | 2006-07-26 | Noven Pharmaceuticals, Inc. | Dispositif multicouche d'administration transdermique de medicaments |
US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
-
2004
- 2004-10-28 GE GEAP20049414A patent/GEP20084561B/en unknown
- 2004-10-28 NZ NZ546992A patent/NZ546992A/xx not_active IP Right Cessation
- 2004-10-28 ES ES04810038.2T patent/ES2626784T3/es active Active
- 2004-10-28 KR KR1020067010411A patent/KR20060114338A/ko not_active Application Discontinuation
- 2004-10-28 CN CNB2004800392144A patent/CN100457064C/zh not_active Expired - Fee Related
- 2004-10-28 ME MEP-2008-235A patent/ME00114B/me unknown
- 2004-10-28 BR BRPI0416063-0A patent/BRPI0416063A/pt not_active Application Discontinuation
- 2004-10-28 JP JP2006538197A patent/JP2007509951A/ja active Pending
- 2004-10-28 RS YUP-2006/0332A patent/RS20060332A/sr unknown
- 2004-10-28 EP EP04810038.2A patent/EP1682061B1/fr active Active
- 2004-10-28 RU RU2006118341/15A patent/RU2356580C2/ru not_active IP Right Cessation
- 2004-10-28 ME MEP-235/08A patent/MEP23508A/xx unknown
- 2004-10-28 CA CA2542778A patent/CA2542778C/fr active Active
- 2004-10-28 WO PCT/US2004/035556 patent/WO2005042055A2/fr active Application Filing
- 2004-10-28 UA UAA200605792A patent/UA84303C2/ru unknown
- 2004-10-28 US US10/975,043 patent/US8703175B2/en active Active
- 2004-10-28 AU AU2004285505A patent/AU2004285505B2/en not_active Ceased
-
2006
- 2006-04-10 IL IL174894A patent/IL174894A0/en unknown
- 2006-04-25 ZA ZA200603300A patent/ZA200603300B/en unknown
- 2006-05-29 NO NO20062434A patent/NO20062434L/no not_active Application Discontinuation
-
2010
- 2010-06-03 US US12/792,940 patent/US20100310610A1/en not_active Abandoned
-
2013
- 2013-07-31 JP JP2013159844A patent/JP2013237691A/ja active Pending
-
2014
- 2014-02-27 US US14/191,900 patent/US20140243764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8703175B2 (en) | 2014-04-22 |
WO2005042055A3 (fr) | 2005-08-25 |
JP2007509951A (ja) | 2007-04-19 |
EP1682061A4 (fr) | 2011-12-07 |
EP1682061B1 (fr) | 2017-03-15 |
US20050169977A1 (en) | 2005-08-04 |
US20140243764A1 (en) | 2014-08-28 |
RS20060332A (en) | 2008-04-04 |
WO2005042055A2 (fr) | 2005-05-12 |
RU2356580C2 (ru) | 2009-05-27 |
UA84303C2 (ru) | 2008-10-10 |
US20100310610A1 (en) | 2010-12-09 |
AU2004285505A1 (en) | 2005-05-12 |
NZ546992A (en) | 2009-07-31 |
BRPI0416063A (pt) | 2007-01-02 |
GEP20084561B (en) | 2008-12-10 |
ES2626784T3 (es) | 2017-07-26 |
AU2004285505B2 (en) | 2010-12-23 |
KR20060114338A (ko) | 2006-11-06 |
ZA200603300B (en) | 2007-07-25 |
CN100457064C (zh) | 2009-02-04 |
CA2542778A1 (fr) | 2005-05-12 |
JP2013237691A (ja) | 2013-11-28 |
CA2542778C (fr) | 2012-05-29 |
ME00114B (me) | 2011-02-10 |
NO20062434L (no) | 2006-07-14 |
CN1901861A (zh) | 2007-01-24 |
RU2006118341A (ru) | 2007-12-20 |
EP1682061A2 (fr) | 2006-07-26 |
IL174894A0 (en) | 2006-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP23508A (en) | Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems | |
ATE464888T1 (de) | Vorrichtung für die transdermale abgabe von wirkstoffen | |
AU2003245547A1 (en) | Bioactive agent release coating and controlled humidity method | |
AU2001251548A1 (en) | Membrane delivery system | |
WO2007044647A3 (fr) | Bandage compressif avec systeme d'administration d'un medicament | |
WO2002092049A3 (fr) | Systeme d'administration d'agents cosmetiques et pharmaceutiques | |
HK1108350A1 (en) | Cooling topical patch preparation | |
ATE319488T1 (de) | Bioaktive-wirkstofffreisetzende beschichtung mit aromatischen poly(meth)acrylaten | |
WO2004103415A3 (fr) | Systeme a pansements multiples pour la gestion de lesions cutanees | |
WO2007011612A3 (fr) | Pansement et procedes pour sa fabrication et son utilisation | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
WO2005018697A3 (fr) | Systemes de distribution d'agents actifs comprenant une seule couche d'un melange de polymeres miscibles, dispositifs medicaux et procedes | |
PT973497E (pt) | Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas | |
GB0606661D0 (en) | Improvements relating to dressings | |
WO2007070649A3 (fr) | Systeme de revetement anti-microbien | |
NO20040319L (no) | Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator | |
ATE288743T1 (de) | Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist | |
WO2006081497A3 (fr) | Formulations et utilisations d'adhesifs hydrophiles biocompatibles | |
WO2006044206A3 (fr) | Dispositif d'administration transdermique de medicaments avec couche support occlusive | |
WO2006009987A3 (fr) | Composition de film dissoluble | |
AR040684A1 (es) | Forma de dosificacion solida recubierta y metodo de preparacion de la misma | |
TW200514590A (en) | Hydrophilic adhesives for delivery of herbal medicines | |
BR0308486A (pt) | Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga | |
WO2010018559A3 (fr) | Formulations pour une gestion en deux phases d'une cicatrisation de lésion et pansements incorporant de telles formulations | |
BRPI0611526A2 (pt) | composição tópica contendo gelatina |